Smoking Cessation for Patients With Acute Coronary Syndrome (ACS) (PATPAC)
Effectiveness of a Managed Care Smoking Cessation Program in Patients With Acute Coronary Syndrome Based on Nicotine Replacement as a Treatment and a Cognitive-behavioral Approach
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ile de France
-
Paris, Ile de France, France, 75010
- CHU Lariboisière, APHP, Cardiology
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients are men and women of less than 70 years old
- Hospitalised for acute coronary syndrome in cardiology Intensive Care Unit
- Active smoking >5 cigarettes/day
- Has given consent to participate in the study and haven't expressed its opposition the exploitation of data as part of the study
Exclusion Criteria:
- Presence of another dependence : alcohol abuse avowed or strongly suspected, addiction to drugs, high dose benzodiazepine dependence. clinical assessment
- Major psychiatric disorders or history. clinical assessment
- Treatment with lithium and neuroleptic. clinical assessment
- Patient whose cardiac problem could lead to hemodynamic instability during 48 h after admission.
- Patient scheduled for programmed hospitalisation within 6 months after release from hospital (>3 days long, including coronary bypass)
- Patients presenting another severe pathology requiring 6 months specific treatments. clinical assessment
- Patient which cannot understand or read French
- Patient with possible side-effect to nicotine substitute
- Patient unaffiliated to any social security regime
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: cognitive behavioural approach
specific technique of cigarette exposure and nicotinic treatment adjustment
|
Nicotine replacement
Other Names:
|
|
Active Comparator: usual approach
recommendations and nicotinic substitutes
|
nicotinic substitutes
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The smoking habits at 6 months classified as : no smoking confirmed by CO measurement, smoking or doubtful (declaration of no smoking by the patient but a CO level > 10 ppm).
Time Frame: 6 month
|
6 month
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Assessment depending of age classes, sex, anxiety scale and other psychological characteristics
Time Frame: 6 month
|
6 month
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Patrick HENRY, MD,PhD, Assistance Publique - Hôpitaux de Paris
- Study Director: Laurent MAGNE, Cabinet MAGNE & GALLY
- Study Director: Olivia GALLY, Cabinet MAGNE & GALLY
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- LRB0801
- EUDRACT : 2008-00267712
- ID RCB : 2008-A00509-46
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.